As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.
Endometriosis and Uterine Fibroid Treatment Study
The purpose of this study is to test the safety and effectiveness of different doses of the investigational study drug, compared to placebo in managing moderate to severe pain associated with endometriosis.
In order to participate you must meet the following criteria:
- Have a clinical diagnosis of endometriosis established by mean of documented laparoscopy or laparotomy.
- Be willing to use 2 forms of non-hormonal contraception.
- Be between 18 and 49 years old.
This is a partial list of elgibility requirements.